Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) advanced 16.62% amid news that the company was commencing a non-deal investor roadshow in the United States with Credit Suisse. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), stock opened at $9.25 in last session, and closed at $9.69, while the day range of PRAN stock is $9.15 – $9.85. The stock showed a positive weekly performance of 36.48%.
Given Imaging Ltd. (Nasdaq:GIVN) announced that at a special shareholders’ meeting held in Yoqneam, Israel, the Company approved the Merger with Ireland’s Covidien plc (NYSE:COV) by shareholders and by the Antitrust Authority. Given Imaging Ltd. (NASDAQ:GIVN), stock opened at $29.96, in last session and closed at $29.96, by gaining 0.03%. The 52 week range of $13.01 – $30.18. Company’s market capitalization is $987.27million.
Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), a pharmaceutical company focused on commercializing novel drug formulations invented by physicians and pharmacists through their clinical experience with patients, announced that it will be attending the 117th Annual Meeting of the American Academy of Ophthalmology (AAO) in New Orleans, November 16-19 (Booth #5058). Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) stock advanced 4.28% and finished the last session at $7.56. The EPS of the stock remained -0.88. Company’s market capitalization is $67.82million.
InfuSystem Holdings Inc (NYSEMKT:INFU), Implements Leading-Edge Electronic Medical Record Data Integration System at Florida-Based Oncology Practice. InfuSystem Holdings Inc (NYSEMKT:INFU) stock opened the session at $2.50, and closed the session at $2.50. The 52 week range of the INFU stock remained $1.27 – $2.88 and the day range was $2.48 – $2.50.